Research & Development

Alisa Lask, Galderma

Alisa Lask, Galderma

Alisa Lask is VP and GM, U.S. aesthetic business unit of Galderma, Nestlé Skin Health.

Elena Cant, Takeda

Elena Cant, Takeda

Elena Cant is VP, global head of vaccine commercial, Takeda Vaccine Business Unit of Takeda.

Deborah Profit, Ostuka

Deborah Profit, Ostuka

Deborah Profit is VP, Otsuka Information Technology at Ostuka.

Vanessa Thirion-Cullity, Novartis Oncology

Vanessa Thirion-Cullity, Novartis Oncology

Vanessa Thirion-Cullity is executive director, U.S. NET of Novartis Oncology.

Heather Bell, Sanofi

Heather Bell, Sanofi

Heather Bell is SVP, global head of digital and analytics of Sanofi.

Ryan Billings, Amag Pharmaceuticals

Ryan Billings, Amag Pharmaceuticals

Ryan Billings is the senior director, digital innovation at Amag Pharmaceuticals.

Ozgun Demir, Novartis

Ozgun Demir, Novartis

Ozgun Demir is the director, digital strategy at Novartis.

Pablo Graiver, Antidote

Pablo Graiver, Antidote

Pablo Graiver is CEO of Antidote.

Dr. Jessica Grossman, Medicines360

Dr. Jessica Grossman, Medicines360

Dr. Jessica Grossman is CEO of Medicines360.

Grant Groves, Boehringer Ingelheim

Grant Groves, Boehringer Ingelheim

Grant Groves is global customer innovation lab, U.S. lead at Boehringer Ingelheim.

Aaron Horowitz, Sproutel

Aaron Horowitz, Sproutel

Aaron Horowitz is cofounder and CEO of Sproutel.

Sarah Krug, Cancer101/Health Collaboratory

Sarah Krug, Cancer101/Health Collaboratory

Sarah Krug is CEO of Cancer101/Health Collaboratory.

Eddie Martucci, Akili Interactive Labs

Eddie Martucci, Akili Interactive Labs

Eddie Martucci is CEO of Akili Interactive Labs.

Joe Meadows, Think Patients

Joe Meadows, Think Patients

Joe Meadows is president of Think Patients.

Laurie Myers, Merck

Laurie Myers, Merck

Laurie Myers is global health literacy director of Merck.

Colleen Reinhart, Edwards Lifesciences

Colleen Reinhart, Edwards Lifesciences

Colleen Reinhart is director, patient marketing and therapy awareness, transcatheter heart valves at Edwards Lifesciences.

Survey: Half of women don't focus on their own health

Survey: Half of women don't focus on their own health

By

GCI Health, HealthyWomen, and Redbook magazine are using survey insights to inform the HealthiHer movement.

ePharma: Boehringer Ingelheim and Aptus Health partner for asthma brand awareness

ePharma: Boehringer Ingelheim and Aptus Health partner for asthma brand awareness

Jim Boushie, director of respiratory marketing at Boehringer Ingelheim (BI) and David Laros, VP of analytics and commercial effectiveness at Aptus Health, came together to lead a joint ePharma session in March titled "Synchronized HCP and consumer campaigns: At the point of care and beyond."

Marketers discuss catalysts for use of behavioral science techniques

Marketers discuss catalysts for use of behavioral science techniques

By

Marketers discuss the biggest catalysts for use of behavioral science techniques in marketing.

Machine Learning Can Decipher Data

Machine Learning Can Decipher Data

As researchers and analysts, we interact with a wide array of market research pros in the health and wellness space.

Five things for pharma marketers to know: Thursday, January 11, 2018

Five things for pharma marketers to know: Thursday, January 11, 2018

By

Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations

Cancer Research UK 'Right Now' campaign returns to highlight research impact

Cancer Research UK 'Right Now' campaign returns to highlight research impact

By

Cancer Research UK's 'Right Now' brand campaign will return in 2018 with a new focus highlighting the impact that research has on people suffering with cancer.

Five things for pharma marketers to know: Thursday, December 14, 2017

Five things for pharma marketers to know: Thursday, December 14, 2017

By

Pharma R&D return on investment falls to eight-year low; FDA approves Pfizer's biosimilar to J&J's Remicade; Novartis to downsize generics business

Gottlieb Eyes Prices, Not Lives

Gottlieb Eyes Prices, Not Lives

It turns out the real goal is going after Washington's favorite whipping boy — high drug prices.

Five things for pharma marketers to know: Wednesday, December 6, 2017

Five things for pharma marketers to know: Wednesday, December 6, 2017

By

FDA approves Novo's diabetes drug; Walgreens undergoes rebranding in the wake of CVS-Aetna merger; pharma increasingly transparent about clinical trial data

Looking Beyond Overall Survival

Looking Beyond Overall Survival

Our understanding of how cancer develops and thrives has grown.

Five things for pharma marketers to know: Thursday, November 2, 2017

Five things for pharma marketers to know: Thursday, November 2, 2017

By

Teva reports lower-than-expected Q3 earnings; BI and Dicerna partner in NASH drug development; AstraZeneca's experimental asthma drug fails in Phase-III

Who's Getting Rich in Healthcare?

Who's Getting Rich in Healthcare?

Do you recall what President Trump tweeted right after Merck's Kenneth Frazier resigned from his American Manufacturing Council?

Five things for pharma marketers to know: Thursday, October 26, 2017

Five things for pharma marketers to know: Thursday, October 26, 2017

By

Non-profit challenges Gilead's Sovaldi patent; The Medicines Company to cut hundreds of jobs; Amgen ends R&D for experimental CETP drug

Nonprofits focus attention on metastatic breast cancer this October

Nonprofits focus attention on metastatic breast cancer this October

By

Susan G. Komen and the Breast Cancer Research Foundation are focusing on raising awareness and research money for the deadliest forms of the disease.